Yngvild K Olsen
Dados Biográficos
| ID | 6061483 |
|---|---|
| NOME | Yngvild K Olsen |
| PRENOMES | Yngvild K |
| SOBRENOME | Olsen |
| ASSINATURA | OLSEN Y K |
| AFILIAÇÕES | At the time of the study, Robert P. Schwartz, Jan Gryczynski, Shannon Gwin Mitchell, and Jerome H. Jaffe are with Friends Research Institute, Baltimore, MD. Kevin E. O’Grady is with the Department of Psychology, University of Maryland College Park, College Park. Joshua M. Sharfstein is with the Maryland Department of Health and Mental Hygiene, Baltimore. Gregory Warren is with Baltimore Substance Abuse Systems, Inc, Baltimore, MD. Yngvild K. Olsen is with the Institutes for Behavioral Resources, Inc,... |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2013 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2015 |
| ÍNDICE H | 0 |
Changes in Quality of Life following Buprenorphine Treatment
Studies of substance abuse treatment outcomes that give priority to cessation of all drug use may obscure other tangible benefits of treatment that are important to patients. The aim of this study was to examine the association between changes in quality of life (QoL) and: (1) retention in treatment; and (2) opioid use as measured by self-report and urine testing. Participants were 300 African American men and women starting outpatient buprenorph…
Schwartz et al. Respond
As reported in our recent article, which found an association between expansion of methadone and buprenorphine treatment and the reduction in heroin overdose deaths in Baltimore, Maryland, between 1995 and 2009, the distribution of the opioid antagonist naloxone is one of a number of public health strategies being employed in the United States and United Kingdom (among other countries) to reduce opioid overdose deaths.1–4 From 2004 through 2009, …
Sem obras proeminentes nesta página.
Schwartz et al. Respond
As reported in our recent article, which found an association between expansion of methadone and buprenorphine treatment and the reduction in heroin overdose deaths in Baltimore, Maryland, between 1995 and 2009, the distribution of the opioid antagonist naloxone is one of a number of public health strategies being employed in the United States and United Kingdom (among other countries) to reduce opioid overdose deaths.1–4 From 2004 through 2009, …
Changes in Quality of Life following Buprenorphine Treatment
Studies of substance abuse treatment outcomes that give priority to cessation of all drug use may obscure other tangible benefits of treatment that are important to patients. The aim of this study was to examine the association between changes in quality of life (QoL) and: (1) retention in treatment; and (2) opioid use as measured by self-report and urine testing. Participants were 300 African American men and women starting outpatient buprenorph…
HIV, Drug Use, Sexual Risk (2 obras) · Medicine (2 obras) · Opioid Use Disorder Treatment (2 obras) · Addiction (1 obras) · Buprenorphine (1 obras) · Environmental health (1 obras) · Internal Medicine (1 obras) · Methadone (1 obras) · Opiate (1 obras) · Opioid (1 obras)